neurodegenerative diseases/アサ属

The present invention relates to cannabinoids for use in the prevention or treatment of neurodegenerative diseases or disorders. Preferably the cannabinoids are cannabichromene (CBC) cannabidivarin (CBDV) and/or cannabidivarin acid (CBDVA). More preferably the neurodegenerative disease or disorder

FIELD OF THE INVENTION The present invention relates to a family of novel non-psychotropic cannabinoids, and to pharmaceutical compositions containing them, which are useful for preventing or alleviating neurotoxicity and inflammation. Said pharmaceutical compositions comprise as their active

FIELD OF THE INVENTION The present invention relates to a family of novel non-psychotropic cannabinoids, and to pharmaceutical compositions containing them, which are useful for preventing or alleviating neurotoxicity and inflammation. Said pharmaceutical compositions comprise as their active

The present invention relates to the use of known agonists of the central cannabinoid receptor CB1 for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma. .DELTA..sup.9 -Tetrahydrocannabinol (.DELTA..sup.9

The present invention relates to the use of known agonists of the central cannabinoid receptor CB1 for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma. .DELTA..sup.9 -Tetrahydrocannabinol (.DELTA..sup.9

BACKGROUND OF THE INVENTION FIELD OF THE INVENTION The present invention relates to the discovery of novel ligands specific for a receptor from the cannabinoid (CB) receptor family. The invention discloses the discovery of novel ligands specific to this receptor that act as antagonists to the

FIELD OF THE INVENTION The present invention relates to a cannabinoid inhaler and a composition therefor. BACKGROUND Cannabinoids have long been known for their therapeutic potential in pain relief, treatment of seizures, antiemesis et cetera. It is, however, a class of compounds whose usage has

FIELD OF THE INVENTION The present invention concerns pharmaceutical compounds and compositions that are useful as tissue protectants, such as neuroprotectants and cardioprotectants. The compounds and compositions may be used, for example, in the treatment of acute ischemic neurological insults or

CROSS REFERENCE TO PRIOR APPLICATIONS This application is a U.S. national phase of International Application No. PCT/IB2006/001437 filed Jun. 1, 2006, which claims priority from Indian Patent Application No. 659/MUM/2005 filed on Jun. 2, 2005, U.S. Provisional Application No. 60/696,433, filed Jul.